HealthCareTips blog: Moderna doses first subject in Omicron-specific booster vaccine trial: This booster merges the company’s Covid-19 vaccine, mRNA-1273, and an Omicron-specific booster candidate, mRNA-1273.529.

Moderna doses first subject in Omicron-specific booster vaccine trial: This booster merges the company’s Covid-19 vaccine, mRNA-1273, and an Omicron-specific booster candidate, mRNA-1273.529.

Moderna doses first subject in Omicron-specific booster vaccine trial: This booster merges the company’s Covid-19 vaccine, mRNA-1273, and an Omicron-specific booster candidate, mRNA-1273.529.

submitted by /u/shallah
[link] [comments]

source https://www.reddit.com/r/Health/comments/tbvkoa/moderna_doses_first_subject_in_omicronspecific/

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)